Showing posts with label ABT. Show all posts
Showing posts with label ABT. Show all posts

9/15/10

Savient Pharma Soars on FDA Approval For Gout Treatment


Monosodium Urate Crystals in Tophaceous Gout
Gout Uric Acid Crystals

From the Wall Street Journal and Reuters: Savient Pharmaceuticals

Wikinvest: (SVNT) Google Finance (SVNT)

Savient shares rally as FDA approves gout drug
Sept 15
Wed Sep 15, 2010 9:15am EDT


The approval is also expected to trigger a renewed interest in the company that has been looking for a strategic deal, and some analysts expect a deal within three to four months.

9/27/09

Abbott to Buy Solvay Drug Unit for $7 Billion NYSE: ABT



This just in from the WSJ. Abbott Labs (ABT) acquires Solvay conglomerate for 7B, or 4.8B eu.

Abbott to Buy Solvay Drug Unit for $7 Billion
Abbott Laboratories has struck a deal to acquire the pharmaceutical unit of Belgian conglomerate Solvay SA for roughly €4.8 billion ($7 billion), in another sign of the consolidation of the drug industry.